NCT01467401 - Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

292

Participants

Timeline

Start Date

August 19, 2002

Primary Completion Date

May 15, 2003

Study Completion Date

May 15, 2003

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart

Individually adjusted dose. Injected subcutaneously (s.c., under the skin) twice daily

DRUG

biphasic human insulin

Individually adjusted dose. Injected subcutaneously (s.c., under the skin) twice daily

Trial Locations (57)

1357

Novo Nordisk Investigational Site, Bekkestua

4300

Novo Nordisk Investigational Site, Holbæk

4700

Novo Nordisk Investigational Site, Næstved

6700

Novo Nordisk Investigational Site, Esbjerg

7400

Novo Nordisk Investigational Site, Herning

7800

Novo Nordisk Investigational Site, Skive

8000

Novo Nordisk Investigational Site, Århus C

8600

Novo Nordisk Investigational Site, Silkeborg

9038

Novo Nordisk Investigational Site, Tromsø

Unknown

Novo Nordisk Investigational Site, Randers

Novo Nordisk Investigational Site, Viborg

Novo Nordisk Investigational Site, Åsgårdstrand

Novo Nordisk Investigational Site, Haugesund

Novo Nordisk Investigational Site, Hønefoss

Novo Nordisk Investigational Site, Moelv

Novo Nordisk Investigational Site, Vennesla

NO-5012

Novo Nordisk Investigational Site, Bergen

0370

Novo Nordisk Investigational Site, Oslo

671 80

Novo Nordisk Investigational Site, Arvika

774 82

Novo Nordisk Investigational Site, Avesta

267 38

Novo Nordisk Investigational Site, Bjuv

280 60

Novo Nordisk Investigational Site, Broby

458 32

Novo Nordisk Investigational Site, Färgelanda

416 65

Novo Nordisk Investigational Site, Gothenburg

416 85

Novo Nordisk Investigational Site, Gothenburg

417 02

Novo Nordisk Investigational Site, Gothenburg

417 17

Novo Nordisk Investigational Site, Gothenburg

467 22

Novo Nordisk Investigational Site, Grästorp

566 32

Novo Nordisk Investigational Site, Habo

871 82

Novo Nordisk Investigational Site, Härnösand

281 25

Novo Nordisk Investigational Site, Hässleholm

254 57

Novo Nordisk Investigational Site, Helsingborg

551 11

Novo Nordisk Investigational Site, Jönköping

651 85

Novo Nordisk Investigational Site, Karlstad

652 24

Novo Nordisk Investigational Site, Karlstad

291 38

Novo Nordisk Investigational Site, Kristianstad

681 80

Novo Nordisk Investigational Site, Kristinehamn

434 80

Novo Nordisk Investigational Site, Kungsbacka

205 02

Novo Nordisk Investigational Site, Malmo

464 30

Novo Nordisk Investigational Site, Mellerud

431 80

Novo Nordisk Investigational Site, Mölndal

602 36

Novo Nordisk Investigational Site, Norrköping

701 85

Novo Nordisk Investigational Site, Örebro

702 15

Novo Nordisk Investigational Site, Örebro

703 51

Novo Nordisk Investigational Site, Örebro

831 62

Novo Nordisk Investigational Site, Östersund

831 83

Novo Nordisk Investigational Site, Östersund

661 81

Novo Nordisk Investigational Site, Säffle

541 85

Novo Nordisk Investigational Site, Skövde

116 91

Novo Nordisk Investigational Site, Stockholm

273 34

Novo Nordisk Investigational Site, Tomelilla

685 29

Novo Nordisk Investigational Site, Torsby

461 40

Novo Nordisk Investigational Site, Trollhättan

461 85

Novo Nordisk Investigational Site, Trollhättan

135 21

Novo Nordisk Investigational Site, Tyresö

451 80

Novo Nordisk Investigational Site, Uddevalla

331 85

Novo Nordisk Investigational Site, Värnamo